CEBPA and fatty liver disease: When exposed to tunicamycin, ATF6α-deficient mice exhibit persistent express CHOP, inhibition of C/EBPα (CCAAT/enhancer-binding protein α), and develop hepatic steatosis (Lebeaupin et al., 2018).